Publication: Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus
Loading...
Program
relationships.isAuthorOf
Author
Yolbas, Servet
Zorlu, MEHMET
Karatoprak, CUMALİ
Kiskac, MUHARREM
CIKRIKCIOGLU, Mehmet Ali
Advisor
Date
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Objective: This study investigated how vildagliptin (a di-peptidyl peptidase 4 inhibitor) affects portal vein pressure and hepatosteatosis in patients with type 2 diabetes mellitus.
Description
Source
Keywords
Keywords
Citation
Karatoprak C., Kilicarslan R., Cakirca M., Aydin S., OZKAN T., KOCAMAN O., Yolbas S., Zorlu M., Kiskac M., CIKRIKCIOGLU M. A. , et al., -Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus-, BEZMIALEM SCIENCE, cilt.6, ss.1-5, 2018